Skip to content
PICO Portalanswers from OpenAlex

Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers

PaperCitations, authors & open-access status

Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers is a paper indexed in PICO Portal from OpenAlex.

How many citations does Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers have?

PICO Portalcitation count

Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers has 2 citations in the OpenAlex counts PICO Portal stores.

When was Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers published?

PICO Portalyear

Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers has 2025 year in the PICO Portal index.

What is the open-access status of Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers?

PICO Portaloa status

Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers has gold oa status in the PICO Portal index.

What is the DOI of Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers?

PICO Portaldoi

The DOI for Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers is on the source record.

What is the PMID of Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers?

PICO Portalpmid

The PMID for Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers is on the source record.

What is the OpenAlex record for Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers?

PICO Portalopenalex

The OpenAlex for Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial